How to perform a structural variant analysis using Luxbio.net?

Understanding the Core Technology: Luxbio’s Genomic Analysis Engine

At the heart of any structural variant analysis on the luxbio.net platform is its proprietary genomic analysis engine. This isn’t just a simple file parser; it’s a sophisticated computational pipeline designed to handle the immense complexity of next-generation sequencing (NGS) data. When you upload your sequencing files—typically in BAM or CRAM format after alignment to a reference genome like GRCh38—the engine initiates a multi-step process. First, it performs quality control checks, flagging any potential issues with read depth, mapping quality, or library preparation artifacts that could lead to false positives. For a standard whole-genome sequencing (WGS) dataset at 30x coverage, this initial QC step might analyze over 90 million read pairs, generating a detailed report on metrics like insert size distribution and GC content. This initial scrutiny is critical; a poor-quality library can render the entire analysis unreliable, so the platform provides clear pass/fail indicators before you proceed.

Step-by-Step: Executing an SV Analysis Workflow

Once your data passes QC, you move into the core analysis phase. Luxbio.net employs a consensus-based approach, leveraging multiple detection algorithms simultaneously to maximize sensitivity and specificity. You’re not limited to a single method. The platform typically runs a combination of read-pair, split-read, read-depth, and assembly-based methods. For instance, it might use Manta, Delly, and Lumpy concurrently. The true power lies in how it reconciles the results. Instead of presenting you with three conflicting lists of variants, the platform’s internal logic cross-references the calls. A deletion called by both Manta and Delly, with supporting split-reads, will be assigned a high-confidence flag. The table below illustrates how a typical trio of algorithms might perform on a simulated dataset, highlighting the strength of a consensus approach.

After the initial calling, you’ll configure filtration parameters. This is where your expertise comes into play. The platform allows you to filter based on a wide array of metrics: variant size (e.g., focus only on variants >50 bp), read support (minimum of 5 supporting reads), allele frequency in population databases like gnomAD-SV, and proximity to difficult genomic regions (segmental duplications, telomeres). You can create and save custom filter sets for different project types—like a stringent set for clinical diagnostics and a more sensitive set for discovery research.

Interpreting the Results: Visualization and Annotation

Getting a list of variants is one thing; understanding their biological and clinical significance is another. Luxbio.net excels at turning data into insight through integrated visualization tools. Clicking on a specific SV, like a 15 kilobase duplication on chromosome 7, launches an interactive viewer. This viewer displays the aligned reads in the region, clearly showing the abnormal mapping patterns that support the call. You can see the split-reads, the discordant read pairs, and the increased read depth indicative of a duplication, all overlaid onto the reference genome. This visual confirmation is invaluable for distinguishing real SVs from sequencing artifacts.

Parallel to visualization, the platform performs comprehensive annotation. Each variant is automatically queried against a suite of databases. This includes:

• Population Frequency: Compared against gnomAD-SV, TOPMed, and DbVar to see if the variant is common and likely benign.
• Functional Impact: Determines if the SV disrupts a gene (e.g., exonic deletion), affects a regulatory element, or is intergenic.
• Phenotypic Association: Cross-referenced with ClinVar and DECIPHER for known links to genetic disorders.
• Conservation: Assessed using metrics like PhyloP to see if the region is evolutionarily conserved.

This annotation process transforms a cryptic genomic coordinate, like “chr17:7668402-7669401(DEL)”, into a biologically meaningful finding: “A 1kb deletion spanning exons 2-3 of the BRCA1 gene, absent from population databases, and classified as pathogenic in ClinVar.”

Advanced Applications: Cancer Genomics and Familial Studies

The utility of Luxbio.net extends far beyond germline analysis in a single sample. For cancer researchers, the platform offers specialized somatic SV calling. Here, the focus shifts to comparing a tumor sample against a matched normal (e.g., patient’s blood) from the same individual. The analysis is tuned to detect somatic variants—those acquired by the tumor cells. The platform calculates a statistical confidence for somatic origin, often using a Fisher’s exact test on the supporting reads in the tumor versus normal. This is crucial for identifying driver mutations, such as gene fusions like BCR-ABL in leukemia or EML4-ALK in lung cancer, which can be targeted by specific therapies. The sensitivity for detecting these fusions in a tumor sample with 20% purity can be as high as 85% for fusions with spanning reads, a critical threshold for clinical actionability.

In familial studies or trio analysis (e.g., proband and parents), the platform provides inheritance mode filtering. After analyzing all three samples, you can quickly filter the proband’s SVs to show only de novo events (absent in both parents), which are a major cause of developmental disorders. Alternatively, you can filter for recessive models, looking for compound heterozygous variants (e.g., a deletion inherited from the mother and a different SV in the same gene inherited from the father). This automated pedigree-aware analysis saves countless hours of manual comparison.

Data Management and Collaboration

A practical but often overlooked aspect of SV analysis is project and data management. Luxbio.net is built as a collaborative environment. You can organize your analyses into projects, invite team members with different permission levels (viewer, analyst, administrator), and maintain a complete audit trail of every analysis step. Every variant call set is versioned, so you can always revert to a previous state or track how interpretations changed with updated databases. For large-scale studies involving hundreds of samples, the batch processing capability is essential. You can queue up dozens of samples, and the platform will process them efficiently in the cloud, sending email notifications upon completion. All raw data, intermediate files, and final results are stored securely in your dedicated workspace, with export options to standard formats like VCF (Variant Call Format) for publication or further analysis in other tools.

The platform’s commitment to utility is also evident in its integration with downstream tools. A simple export function generates a file formatted for input into tools like IGV (Integrative Genomics Viewer) for manual review, or into gene list enrichment analysis platforms. This eliminates the tedious data reformatting that often bogs down bioinformatic workflows, allowing you to move seamlessly from discovery to validation and interpretation. The entire process, from raw data upload to a finalized, annotated list of high-confidence structural variants, is streamlined into a single, cohesive environment designed for both power and usability.